Z. Ping Lin
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 15
- PARP inhibition in cancer therapy 9
- Cancer-related Molecular Pathways 4
- Metal complexes synthesis and properties 2
-
- DNA Repair Mechanisms 7
- Ubiquitin and proteasome pathways 2
- RNA modifications and cancer 2
- Co-authors
- Alan C. Sartorelli (9 shared papers)Elena Ratner (13 shared papers)Jana S. Eaton (2 shared papers)Gerald S. Shadel (2 shared papers)Nicholas D. Bonawitz (1 shared paper)Joseph G. Cory (3 shared papers)Michael F. Belcourt (3 shared papers)Yong-Lian Zhu (6 shared papers)
- Journals
- Molecular Pharmacology (2 papers)PLoS ONE (2 papers)Scientific Reports (2 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)iScience (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Z. Ping Lin
22 papers receiving 682 citations
Peers
Comparison fields: 5 of 72
- Oncology 277
- Reproductive Medicine 58
- Cancer Research 97
- Molecular Biology 443
- Cell Biology 50
Countries citing papers authored by Z. Ping Lin
This map shows the geographic impact of Z. Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Ping Lin more than expected).
Fields of papers citing papers by Z. Ping Lin
This network shows the impact of papers produced by Z. Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Ping Lin. The network helps show where Z. Ping Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Z. Ping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 154 | |
| 2 | 2014 | 119 | |
| 3 | 2004 | 69 | |
| 4 | 2018 | 48 | |
| 5 | Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance. | 1998 | 48 |
| 6 | 2012 | 41 | |
| 7 | 2006 | 35 | |
| 8 | 2014 | 34 | |
| 9 | 2016 | 30 | |
| 10 | 2018 | 29 | |
| 11 | 2016 | 20 | |
| 12 | 2011 | 15 | |
| 13 | 2001 | 11 | |
| 14 | 2021 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2024 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2023 | 4 | |
| 19 | Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of I kappa B alpha. | 2001 | 3 |
| 20 | 2025 | 1 |
About Z. Ping Lin
Z. Ping Lin is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 688 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), DNA Repair Mechanisms (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer-related Molecular Pathways (4 papers), NF-κB Signaling Pathways (3 papers), Ubiquitin and proteasome pathways (2 papers), Metal complexes synthesis and properties (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (277 citations), Reproductive Medicine (58 citations), Cancer Research (97 citations), Molecular Biology (443 citations) and Cell Biology (50 citations). Z. Ping Lin has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Alan C. Sartorelli, Elena Ratner, Jana S. Eaton, Gerald S. Shadel, Nicholas D. Bonawitz, Joseph G. Cory, Michael F. Belcourt, Yong-Lian Zhu, Yashang Lee and Yang Yang‐Hartwich. Their work appears in journals such as Molecular Pharmacology, PLoS ONE, Scientific Reports, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.